Kelvin Chan

Dr. Kelvin Chan is a Medical Oncologist at the Sunnybrook Odette Cancer Centre, a Professor at the University of Toronto, and an associate scientist at the Sunnybrook Research Institute. He has completed both an MSc and a PhD in Biostatistics, and also holds an MSc in Clinical Epidemiology.

Dr. Chan’s research focuses on the different aspects of the value of cancer drugs, including health economics, health technology assessment, and real-world evidence. He is the Co-Director at the Canadian Centre for Applied Research in Cancer Control (ARCC), funded by the Canadian Cancer Society (CCS).

Dr. Chan is especially interested in cancer drug reimbursement related issues. He is a member of multiple provincial and national committees related to cancer drug assessments and recommendations including the pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC), the Committee to Evaluate Drugs (CED) and the Ontario Steering Committee of Cancer Drugs (OSCCD. He was also the Clinical Lead for the Provincial Drug Reimbursement Programs (PDRP) at Ontario Health – Cancer Care Ontario (OH-CCO), from September 2014 to July 2024.

Education

• PhD, 2017, Biostatistics (focusing on statistical methods in health economic evaluations), University of Toronto, Dalla Lana School of Public Health, Toronto, Ontario, Canada, Supervisor(s): Dr. Eleanor Pullenayegum and Dr. Andy Willan
• MSc, 2010, Biostatistics, University of Toronto, Dalla Lana School of Public Health, Toronto, Ontario, Canada
• MSc, 2007, Health Administration (Clinical Epidemiology), University of Toronto, School of Graduate Studies, Toronto, Ontario, Canada
• M.D. with Honours, 1999, University of Toronto, Faculty of Medicine, Toronto, Ontario, Canada
• Hons B.Sc. with High Distinction, 1995, Human Biology, University of Toronto, Faculty of Arts and Science, Toronto, Ontario, Canada

Appointments & Affiliations

• Associate Scientist, Evaluative Clinical Sciences, Odette Cancer Research Program, Sunnybrook Research Institute, Full Status, Adjunct Scientist, ICES
• Full Professor, Faculty of Medicine and the Institute of Health Policy, Management and Evaluation (iHPME), University of Toronto
• Medical Oncology Lead, Gastrointestinal Cancer Disease Site Group, Odette Cancer Centre, Sunnybrook Health Sciences Centre
• Medical Oncology Lead, Head & Neck Cancer Disease Site Group, Odette Cancer Centre, Sunnybrook Health Sciences Centre
• Staff Medical Oncologist, Odette Cancer Centre (Major disease site: GI), Sunnybrook Health Sciences Centre